US regulators review Moderna application

by Joshua S. Weitz Reposted by Mark D. White

Scholar power: 10.1%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Joshua S. Weitz	4%	64	9.6%
🎓 Mark D. White	1%	29	0.5%
Total			10.1%

Formula for scholar power: 3 × author's field match × √author's h-index + sum of each reposter's field match × √reposter's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

78.0%

18.2 h

273

10.1%

Ranking score

0.239

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

Joshua Weitz

@joshuasweitz.bsky.social

Public pushback matters... and reveals levers of power.

www.statnews.com/2026/02/18/f...

FDA reverses course, agrees to review Moderna’s flu vaccine

The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced Wednesday.

www.statnews.com

February 18, 2026 at 1:00 PM

Reposted by Trudy Harpham

7%

Scholar power: 7.6%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Trudy Harpham	12%	40	7.6%

Formula for scholar power: sum of each reposter's field match × √reposter's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

84.0%

17.2 h

661

7.6%

Ranking score

0.223

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

by Timothy D. McBride

25%

Scholar power: 25.9%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Timothy D. McBride	18%	23	25.9%

Formula for scholar power: 3 × author's field match × √author's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

80.0%

18.4 h

72

25.9%

Ranking score

0.197

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

Timothy McBride

@mcbridetd.bsky.social

FDA reverses course, agrees to review Moderna’s flu vaccine www.statnews.com/2026/02/18/f...

FDA reverses course, agrees to review Moderna’s flu vaccine

The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced Wednesday.

www.statnews.com

February 18, 2026 at 12:45 PM

Reposted by Naftali Kaminski

9%

Scholar power: 9.2%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Naftali Kaminski	9%	104	9.2%

Formula for scholar power: sum of each reposter's field match × √reposter's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

78.0%

18.9 h

51

9.2%

Ranking score

0.085

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

Reposted by Elizabeth Saunders, Paul Goldsmith-Pinkham

2%

Scholar power: 2.8%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Elizabeth Saunders	4%	33	2.3%
🎓 Paul Goldsmith-Pinkham	1%	30	0.5%
Total			2.8%

Formula for scholar power: sum of each reposter's field match × √reposter's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

83.0%

17.2 h

106

2.8%

Ranking score

0.084

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

The New York Times

@nytimes.com

Breaking News: The FDA reversed its decision on Moderna’s mRNA flu vaccine and agreed to review it for possible approval, Moderna said.

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.

nyti.ms

February 18, 2026 at 1:55 PM

by Timothy D. McBride

25%

Scholar power: 25.9%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Timothy D. McBride	18%	23	25.9%

Formula for scholar power: 3 × author's field match × √author's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

80.0%

11.8 h

3

25.9%

Ranking score

0.113

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

Timothy McBride

@mcbridetd.bsky.social

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine www.nytimes.com/2026/02/18/h...

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

www.nytimes.com

February 18, 2026 at 7:21 PM

Reposted by Trudy Harpham

7%

Scholar power: 7.6%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Trudy Harpham	12%	40	7.6%

Formula for scholar power: sum of each reposter's field match × √reposter's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

80.0%

17.6 h

41

7.6%

Ranking score

0.076

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

Reposted by Simon Roux

2%

Scholar power: 2.5%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Simon Roux	3%	70	2.5%

Formula for scholar power: sum of each reposter's field match × √reposter's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

79.0%

16.2 h

214

2.5%

Ranking score

0.073

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

Scientific American

@sciam.bsky.social

After initially rejecting Moderna’s application for review, the FDA will now consider the mRNA flu shot

FDA agrees to review Moderna mRNA flu vaccine in dramatic reversal

After initially rejecting Moderna’s application for review, the FDA will now consider the mRNA flu shot

www.scientificamerican.com

February 18, 2026 at 2:58 PM

by Timothy D. McBride

25%

Scholar power: 25.9%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Timothy D. McBride	18%	23	25.9%

Formula for scholar power: 3 × author's field match × √author's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

74.0%

11.8 h

3

25.9%

Ranking score

0.09

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

Timothy McBride

@mcbridetd.bsky.social

Moderna says the FDA will consider its new flu shot after resolving a public dispute abcnews.com/Health/wireS...

Moderna says the FDA will consider its new flu shot after resolving a public dispute

Vaccine maker Moderna says the Food and Drug Administration will decide whether to approve its new flu shot for older adults after all

abcnews.com

February 18, 2026 at 7:20 PM

by Amir Attaran

18%

Scholar power: 18.4%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Amir Attaran	11%	31	18.4%

Formula for scholar power: 3 × author's field match × √author's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

71.0%

11.1 h

1

18.4%

Ranking score

0.055

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

Amir Attaran

@amirattaran.bsky.social

LOL they revered their decision after one week. It’s TACO, health science version.

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

www.nytimes.com

February 18, 2026 at 8:04 PM

Reposted by David R. Miller, David Darmofal

0%

Scholar power: 0.0%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 David R. Miller	0%	21	0.0%
🎓 David Darmofal	0%	11	0.0%
Total			0.0%

Formula for scholar power: sum of each reposter's field match × √reposter's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

80.0%

18.3 h

108

0.0%

Ranking score

0.051

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

Jill Lawrence

@jilldlawrence.bsky.social

Big news from @lizzylawrence.bsky.social: FDA reverses course, agrees to review Moderna’s flu vaccine www.statnews.com/2026/02/18/f... via @statnews.com

FDA reverses course, agrees to review Moderna’s flu vaccine

The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced Wednesday.

www.statnews.com

February 18, 2026 at 12:55 PM

by Timothy D. McBride

25%

Scholar power: 25.9%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Timothy D. McBride	18%	23	25.9%

Formula for scholar power: 3 × author's field match × √author's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

62.0%

18.5 h

12

25.9%

Ranking score

0.057

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

Timothy McBride

@mcbridetd.bsky.social

Opinion: I was a Moderna exec when the Covid vaccine rolled out. That spirit of possibility has been destroyed by anti vaxxers
www.statnews.com/2026/02/18/m...

I was a Moderna exec when the Covid vaccine rolled out. That spirit of possibility is no more

“The pharmaceutical industry is not the enemy,” writes Richard Hughes IV, who was Moderna’s VP for public policy when the Covid vaccine rolled out.

www.statnews.com

February 18, 2026 at 12:37 PM

Reposted by Brendan Nyhan

0%

Scholar power: 0.7%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Brendan Nyhan	1%	51	0.7%

Formula for scholar power: sum of each reposter's field match × √reposter's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

78.0%

17.4 h

132

0.7%

Ranking score

0.048

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

Helen Branswell 🇨🇦

@helenbranswell.bsky.social

#FDA backs down on #Moderna: The agency had refused to review the company's licensure application for an mRNA flu vaccine, but after significant pushback has relented. www.statnews.com/2026/02/18/f...

FDA reverses course, agrees to review Moderna’s flu vaccine

The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced Wednesday.

www.statnews.com

February 18, 2026 at 1:45 PM

Reposted by Richard E. Lenski

5%

Scholar power: 5.3%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Richard E. Lenski	5%	111	5.3%

Formula for scholar power: sum of each reposter's field match × √reposter's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

49.0%

6.2 h

31

5.3%

Ranking score

0.028

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

Princess Vimentin PhD | Cancer Biologist

@princess-vimentin.bsky.social

Doing science in the US is starting to feel untenable. The CDC has had no stable leader. RFK Jr broke his promises on vaccines & research. Climate change is denied. Moderna will no longer invest in late stage vaccine trials. Europe and China are seizing the moment.
🧪 bit.ly/3ZF0yzI

Brain drain is undermining America’s scientific edge

Policy decisions grounded in Maga talking points are helping to fuel a PhD exodus from government

www.ft.com

February 19, 2026 at 12:56 AM

by Olúfẹ́mi Táíwò

3%

Scholar power: 3.8%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Olúfẹ́mi Táíwò	3%	18	3.8%

Formula for scholar power: 3 × author's field match × √author's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

72.0%

10.3 h

2

3.8%

Ranking score

0.027

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

Olúfẹ́mi O. Táíwò

@olufemiotaiwo.bsky.social

"In an announcement Wednesday morning, Moderna said the FDA has now agreed to review its vaccine after the company held a formal (Type A) meeting with the FDA and proposed a change to the regulatory pathways used in the application."

weird

February 18, 2026 at 8:54 PM

by Lisa W. Fazio

8%

Scholar power: 8%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Lisa W. Fazio	-	29	-

Lisa Fazio

@lkfazio.bsky.social

The fight isn't over but this is very very good news.

www.statnews.com/2026/02/18/f...

FDA reverses course, agrees to review Moderna’s flu vaccine

The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced Wednesday.

www.statnews.com

February 18, 2026 at 1:25 PM

Reposted by Rita Rubin

5%

Scholar power: 5.3%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Rita Rubin	16%	11	5.3%

Formula for scholar power: sum of each reposter's field match × √reposter's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

58.0%

12.6 h

22

5.3%

Ranking score

0.023

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

Seth Trueger

@mdaware.org

FDA Reverses Course and Will Now Review Moderna’s Flu Shot
Company’s mRNA flu shot, if approved, could be available for the 2026-27 flu season
By Peter Loftus and Liz Essley Whyte
Feb. 18, 2026 9:12 am ET.

The move means that Moderna’s experimental flu shot is largely back on track after the FDA’s surprise decision earlier this month to refuse to start a review of its application. The decision came after discussions with White House and health department officials, people familiar with the matter said. Moderna said it also met with the FDA and proposed a revised approach.

February 18, 2026 at 6:36 PM

Reposted by Lindsay M. Tedds

0%

Scholar power: 0.6%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Lindsay M. Tedds	2%	10	0.6%

Formula for scholar power: sum of each reposter's field match × √reposter's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

85.0%

18.6 h

85

0.6%

Ranking score

0.022

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

Lizzy Lawrence

@lizzylawrence.bsky.social

BREAKING: FDA reverses course and will now review Moderna's flu vaccine, the company announced Wednesday www.statnews.com/2026/02/18/f...

FDA reverses course, agrees to review Moderna’s flu vaccine

The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced Wednesday.

www.statnews.com

February 18, 2026 at 12:34 PM

by David Kaufman

15%

Scholar power: 15.9%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 David Kaufman	8%	44	15.9%

Formula for scholar power: 3 × author's field match × √author's h-index

Ranking score inputs

Relevance

Recency

Reposts

Scholar power

46.0%

7.5 h

1

15.9%

Ranking score

0.02

Formula for ranking score (post): scholar_power × max((total_reposts)^(1/3), 1) × (1 / max(hours_since_posted, 1)) × (raw_relevance)^3

David Kaufman

@kaufmanmd.bsky.social

But RFK and the other idiots who have taken over the CDC, FDA, and HHS would prefer to see that 50% be hospitalized and/or killed.
Brilliant plan. Ignorance and blind ideology kills.

Eric Topol @erictopol.bsky.social · 7h

In people age 50+, the Covid booster halved hospitalization and deaths.
Waning of benefit after 3-6 months
For the mRNA BA.1 booster vs no shot after initial vaccination
www.sciencedirect.com/science/arti...

February 18, 2026 at 11:41 PM

by Juan Cole

7%

Scholar power: 7%

Story's scientific field profile

Medicine 38%, Public Health 24%, Pharmacology, Toxicology and Pharmaceutics 24%, Law 14%

Name	Field match	H-index	Scholar power
🎓 Juan Cole	-	24	-

Juan Cole

@jricole.bsky.social

Every day Republican death cult finds new ways to kill Americans - U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says flip.it/lR5vOz

U.S. rejection of new mRNA flu vaccine 'sends chills,' epidemiologist says

The U.S. Food and Drug Administration announced recently that it will not review Moderna’s mRNA flu vaccine, despite late-stage trials showing it was safe and effective. The rejection has many in and ...

flip.it

February 18, 2026 at 4:21 PM

Add to Home Screen

Light up
your news

US regulators review Moderna application

Add to Home Screen

Light upyour news

US regulators review Moderna application

Scholar power: 10.1%

Scholar power: 7.6%

Scholar power: 25.9%

Scholar power: 9.2%

Scholar power: 2.8%

Scholar power: 25.9%

Scholar power: 7.6%

Scholar power: 2.5%

Scholar power: 25.9%

Scholar power: 18.4%

Scholar power: 0.0%

Scholar power: 25.9%

Scholar power: 0.7%

Scholar power: 5.3%

Scholar power: 3.8%

Scholar power: 8%

Scholar power: 5.3%

Scholar power: 0.6%

Scholar power: 15.9%

Scholar power: 7%

Sign in to Lightnews

Sign up to start reading

Connect Bluesky

Connect with Bluesky

Light up
your news